Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Report of ThromboSol efficacy presented at hematology congress

Jan. 9, 1998

BioChem Pharma/Scriptgen conclude licensing and equity agreements

Jan. 8, 1998

Drug discovery collaboration established by Aurora and Merck

Jan. 7, 1998

CIMA terminates one and initiates another OraSolv agreement

Jan. 2, 1998

Genetronics develops new transdermal delivery method suitable for large molecules and genes

Dec. 30, 1997

Bayer/Genzyme drug discovery collaboration

Dec. 24, 1997

Therapeutics discovery collaboration formed by Ontogeny and ArQule

Dec. 23, 1997

New prodrug approach claimed by Merck & Co.

Dec. 23, 1997

Cel-Sci and NCI to test L.E.A.P.S. in NCI animal models of cancer

Dec. 22, 1997

Antibody-based therapeutics alliance formed by CAT and Icos

Dec. 22, 1997

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...